Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B & EPS of $1.55. Recent acquisition of SPR Therapeutics adds to neuromodulation business. Analyst ratings show mixed op...
MiniMed, the diabetes business of medical device maker Medtronic , said on Thursday it has raised $560 million in its U.S. initial public offering. The diabetes care company, which makes insulin pu...
Medtronic’s MiniMed Group said on Tuesday it was aiming for a valuation of up to $7.86 billion in its initial public offering in the United States, advancing the medical device maker’s pla...
MiniMed Group Inc., a diabetes management firm that will be separated from health care giant Medtronic Plc, filed for an initial public offering, disclosing growing revenue and a shrinking net loss. M...
Medtronic’s MiniMed Group filed for a U.S. initial public offering on Friday, as the medical device maker moves ahead with the spin-off of its diabetes business. With capital markets set for a s...
